(Recorded Webinar) Protecting Patient Information Related to Substance Use Disorders: Determining if 42 CFR Part 2 Applies and How to Comply (September 2017)
In February 2017 the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a Final Rule updating the protections for patient substance use disorder information under 42 CFR Part 2. These protections, collectively referred to as “Part 2”, apply to federally assisted “programs” that provide substance use disorder diagnosis, treatment or referral, as well to “lawful holders” of information protected by Part 2. The Part 2 requirements are separate from and more restrictive than the HIPAA Privacy Rule protections. This webinar will help health centers determine whether Part 2 applies and will highlight compliance requirements related to key Part 2 compliance concerns, including patient consent and records management.
As Compliance Counsel with the firm’s health law practice group, Dianne advises health centers on implementing effective compliance programs and on addressing top compliance risk areas. Dianne counsels health centers and other organizations on developing compliance programs that include the OIG’s seven elements, respond to identified compliance risk areas and reflect the organization’s culture. Dianne also advises health centers and other organizations on patient privacy and confidentiality, including the HIPAA Privacy Rule and 42 CFR Part 2. She has experience responding to privacy and security incidents, including determining whether there has been a breach, notifying patients and the government, and creating corrective action plans. [Full Bio]
A summer associate in 2013, David joined the firm on a full-time basis shortly after graduation. As an associate in the Health Law and Federal Grants practice groups, David assists in matters pertaining to litigation and compliance by conducting legal research and drafting documents that further client interests.[Full Bio]
Certificates of Attendance are available for all webinars (both live and recorded) for the registered attendee upon completion of the webinar.
A blank Certificate of Attendance will be available for organizations to issue to attendees that viewed the webinar (either live or on-demand). Due to the online nature of the training course, Feldesman Tucker Leifer Fidell LLP does not certify that the attendee actually viewed the course. A supervisor at the organization should sign the certificate, and therefore, certifies that the attendee viewed the course.
Attendance record forms are available for all webinars (live and on-demand) and can be utilized to record the attendance of numerous staff members for internal purposes.
Read more about maintaining an attendance record in our FAQs.
Recorded webinars are available for 90 days after the date of purchase or date of the webinar. Once your purchase is complete, you can re-access the webinar at any time by clicking “My Account” in the upper right hand corner of the page or by clicking the “My Training” tab (found at the top of any page on learning.ftlf.com) and clicking on webinar title.
An unlimited number of participants can experience the recorded webinar by broadcasting it on a projection screen and watching it together. A single login can gain access to the webinar and be issued a certificate. The record of attendance form can be accessed under the certificate link within the activity. For more information on live and recorded webinars, please refer to our FAQ section.
If you selected a payment option other than Credit Card, access to the recorded webinar will be granted within 3 business days. Once you are granted access you will receive a confirmation email. FTLF reserves the right to suspend access to the webinar if payment is not received within 30 days.
REFUND/ CANCELLATION POLICY
No refunds are provided for recorded webinars. FTLF can accommodate transferring the registration to someone else within your organization or transferring the registration to another on-demand or upcoming live webinar provided that the webinar has not been viewed.
Google Chrome and Mozilla Firefox are the preferred browsers.